Annals of Internal Medicine (2004) Finland pioneers international suicide prevention. Annals of Internal Medicine, 140, 853–856.
Barbui, C., Campomori, A., D'Avanzo, B., et al (1999) Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Social Psychiatry & Psychiatric Epidemiology, 34, 152–156.
Cantor, C. H. (2000) Suicide in the Western world. In The International Handbook of Suicide and Attempted Suicide (eds Hawton, K. & van Heeringen, K., pp. 9–28. Chichester: John Wiley & Sons.
Carlsten, A., Waern, M., Ekedahl, A., et al (2001) Antidepressant medication and suicide in Sweden. Pharmacoepidemiology and Drug Safety, 10, 525–530.
Fergusson, D., Doucette, S., Cranley Glass, K., et al (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ, 330, 396–399
Grunebaum, M. F., Ellis, S. P., Li, S., et al (2004) Antidepressants and suicide risk in the United States, 1985–1999. Journal of Clinical Psychiatry, 65, 1456–1462
Gunnell, D. & Ashby, D. (2004) Antidepressants and suicide: what is the balance of benefit and harm?
BMJ, 329, 34–38.
Gunnell, D., Middleton, N., Whitley, E., et al (2003) Why are suicide rates rising in young men but falling in the elderly? A time-series analysis of trends in England and Wales, 1950–1998. Social Science and Medicine, 57, 595–611.
Gunnell, D., Saperia, J. & Ashby, D. (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: a meta-analysis of drug company data from placebo-controlled randomised controlled trials submitted to the MHRA's safety review. BMJ, 330, 385–388.
Hall, W. D., Mant, A., Mitchell, P. B., et al (2003) Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ, 326, 1008–1011.
Healy, D. (2003) Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics, 72, 71–79.
Helgason, T., Tomasson, H. & Zoega, T. (2004) Antidepressants and public health in Iceland. Time series analysis of national data. British Journal of Psychiatry, 184, 157–162.
Isacsson, G. (2000) Suicide prevention – a medical breakthrough?
Acta Psychiatrica Scandinavica, 102, 113–117.
Kim, H. J., Fay, M. P., Feuer, E. J., et al (2000) Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19, 335–351.
Martinez, C., Rietbrock, S., Wise, L., et al (2005) Antidepressant treatment and the risk of fatal and nonfatal self-harm in first-episode depression – a nested case–control study. BMJ, 330, 389–393.
Medicines and Healthcare products Regulatory Agency (2004) Report of the Committee on Safety of Medicines Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitors. London: TSO (The Stationery Office).
Middleton, N., Gunnell, D., Whitley, E., et al (2001) Secular trends in antidepressant prescribing in the UK, 1975–1998. Journal of Public Health Medicine, 23, 262–267.
Olfson, M., Shaffer, D., Marcus, S. C., et al (2003) Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry, 60, 978–982.
Rihmer, Z., Belso, N. & Kalmar, S. (2001) Antidepressants and suicide prevention in Hungary. Acta Psychiatrica Scandinavica, 103, 238–239.
Whittington, C. J., Kendall, T., Fonagy, P., et al (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363, 1341–1345.